Targeted modulation of the neuroinflammatory response after spinal cord injury: the ongoing quest for the "holy grail".
This Commentary discusses the role of inflammation after spinal cord injury.
Department of Orthopaedic Surgery, University of Colorado Denver, School of Medicine Denver Health Medical Center, 777 Bannock Street, Denver, CO 80204, USA. philip.stahel@dhha.org
Philip F
PF
Stahel
Michael A
MA
Flierl
D000818:Animals; D011415:Complement Factor B / Q000037:antagonists & inhibitors / Q000235:genetics / Q000276:immunology; D003170:Complement Pathway, Alternative / Q000276:immunology / Q000502:physiology; D006801:Humans; D007167:Immunotherapy / Q000379:methods / Q000639:trends; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends*; D009187:Myelitis / Q000209:etiology / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D013119:Spinal Cord Injuries / Q000150:complications / Q000276:immunology* / Q000628:therapy*
D011415:Complement Factor B